研究单位:[1]Peking University First Hospital[2]Peking University People's Hospital[3]Beijing Hospital[4]Navy General Hospital,Beijing[5]Beijing Aerospace General Hospital[6]Qilu Hospital of Shandong University[7]Beijing Tongren Hospital
研究目的:
Randomized, open-label, multicenter study to compare the efficacy and safety of ATRA plus high-dose dexamethasone compared to high-dose dexamethasone monotherapy for the first-line treatment of adults with primary immune thrombocytopenia (ITP).